# The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis

> **NCT01455220** · NA · COMPLETED · sponsor: **University of South Florida** · enrollment: 45 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Tysabri ® (Natalizumab)

## Key facts

- **NCT ID:** NCT01455220
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2017-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01455220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01455220, "The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01455220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*